NRGEX | SPWAX | NRGEX / SPWAX | |
Total Expense Ratio | 0.03 | 1.29 | 2% |
Annual Report Gross Expense Ratio | 0.69 | 1.57 | 44% |
Fund Existence | 4 years | 13 years | - |
Gain YTD | -2.076 | 6.319 | -33% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 0 | 2500 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 9.11B | 409M | 2,228% |
Annual Yield % from dividends | 0.54 | 0.00 | - |
Returns for 1 year | -2.66 | 2.81 | -95% |
Returns for 3 years | -2.78 | -0.48 | 580% |
Returns for 5 years | N/A | -20.19 | - |
Returns for 10 years | N/A | -21.80 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BBH | 166.86 | 1.82 | +1.10% |
VanEck Biotech ETF | |||
GDO | 11.98 | 0.01 | +0.08% |
Western Asset Global Corporate Opportunity Fund Inc | |||
QCAP | 23.09 | 0.01 | +0.03% |
FT Vest Nasdaq-100 Cnsrv Buffr ETF - Apr | |||
HDLB | 16.38 | N/A | N/A |
ETRACS Mny Py 2xLgd US Hg Dv Lw Vl ETN B | |||
NUV | 8.60 | -0.04 | -0.46% |
Nuveen Municipal Value Fund |